Bioxytran (BIXT) Receivables (2012 - 2019)
Bioxytran (BIXT) posted Receivables of $50000.0 for Q4 2019, up 941.67% sequentially from $4800.0 in Q2 2018.
Bioxytran (BIXT) Receivables (2012 - 2019) Analysis & Trends
Bioxytran has reported Receivables for 8 years, with the latest figure at $50000.0 in Q4 2019.
- Quarterly Receivables changed N/A year-over-year to $50000.0 in Q4 2019, while the trailing twelve-month figure through Dec 2019 was $50000.0 (changed N/A YoY) and the FY2019 annual result came in at $100000.0, changed N/A from the prior year.
- Receivables climbed to $50000.0 in Q4 2019 per BIXT's latest filing, from $4800.0 in the prior quarter.
- Over five years, Receivables peaked at $50000.0 in Q4 2019 and troughed at $2039.0 in Q1 2018.
- A 5-year average of $22030.8 and a median of $22350.5 in 2015 frame the typical range for Receivables.
- The sharpest annual moves came in 2015 and 2017: Receivables plunged 98.06% in 2015, then surged 139.16% in 2017.
- Over 5 years, Receivables stood at $21742.0 in 2015, then tumbled by 55.85% to $9600.0 in 2016, then soared by 139.16% to $22959.0 in 2017, then tumbled by 79.09% to $4800.0 in 2018, then surged by 941.67% to $50000.0 in 2019.
- According to Business Quant data, Receivables over the past three periods registered $50000.0, $4800.0, and $2039.0 for Q4 2019, Q2 2018, and Q1 2018 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 2.13 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 6.57 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 1.93 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 160.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 1.06 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 912.74 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 215.33 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 1.09 Bn |
| 10 | Bioxytran | 2.47 Mn | 2.22 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | 50,000.00 |
| Jun 30, 2018 | 4,800.00 |
| Mar 31, 2018 | 2,039.00 |
| Dec 31, 2017 | 22,959.00 |
| Sep 30, 2017 | 36,269.00 |
| Dec 31, 2016 | 9,600.00 |
| Sep 30, 2016 | 30,240.00 |
| Sep 30, 2015 | 21,742.00 |
| Jun 30, 2015 | 40,342.00 |
| Mar 31, 2015 | 2,317.00 |
| Sep 30, 2014 | 75,434.00 |
| Jun 30, 2014 | 91,098.00 |
| Mar 31, 2014 | 119,156.00 |
| Dec 31, 2013 | 58,328.00 |
| Sep 30, 2013 | 38,208.00 |
| Jun 30, 2013 | 47,673.00 |
| Mar 31, 2013 | 49,702.00 |
| Dec 31, 2012 | 27,406.00 |
| Sep 30, 2012 | 38,544.00 |
| Jun 30, 2012 | 112,937.00 |